A groundbreaking pilot study from Bournemouth University suggests that the origins of endometriosis, a debilitating condition affecting one in ten women, may lie in a complex interaction between our ancient genetic heritage and the modern chemical environment. This new hypothesis proposes that
With the biopharmaceutical world still buzzing from the latest data presented at the American Society of Hematology meeting, we sat down with industry expert Ivan Kairatov to unpack the results that have sent one company's stock soaring. At the center of the discussion is TERN-701, an experimental
Picture a medical landscape where treatments can slip past the body's toughest defenses, delivering healing payloads directly to diseased cells without harming the surrounding healthy tissue. This isn't science fiction but the tantalizing promise of engineered exosomes—tiny biological couriers that
Imagine a world where the most abundant immune cells in the human body, crucial for fighting infections, remain a mysterious black box to scientists and medical professionals. For too long, neutrophils—those rapid-response warriors of the immune system—have been just that, with their complex
Imagine a world where the trial-and-error nature of drug discovery is replaced by a precise, predictive system capable of designing therapies for some of humanity’s most stubborn diseases. This vision is no longer a distant dream but a tangible goal for insitro, a South San Francisco-based AI
Imagine a world where life-saving drugs reach patients faster, with fewer animals harmed and costs slashed by millions. This isn’t a distant dream but a tangible goal as the U.S. Food and Drug Administration (FDA) pivots toward human-relevant drug safety models. With new draft guidance released
